Video Experimental Relacionado
Updated: Sep 10, 2025
06:08
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
10.7K
Análisis de los marcos legislativos y reglamentarios que rigen la farmacia comunitaria en Bulgaria y Macedonia del
Anna Todorova1, Mariya Ivanova1, Magdalena Pesheva1
1Faculty of Pharmacy, Medical University of Varna, 9000 Varna, Bulgaria.
Pharmacy (Basel, Switzerland)
|August 27, 2025
Resumen
Este estudio compara las regulaciones comunitarias de farmacia en Bulgaria y Macedonia del Norte. Macedonia del Norte muestra un mejor acceso farmacéutico rural a pesar de que ambos países superan los promedios de farmacias de la UE.
Área de la Ciencia:
- Política de salud
- Servicios farmacéuticos
- Legislación comparada
Sus antecedentes:
- Bulgaria, miembro de la UE, y Macedonia del Norte, candidata a la UE, comparten una frontera y intereses regulatorios.
- La comparación de sus marcos legislativos para las farmacias comunitarias ofrece información sobre la armonización de la UE y los sistemas de salud regionales.
Objetivo del estudio:
- Analizar comparativamente los marcos regulatorios de las farmacias comunitarias en Bulgaria y Macedonia del Norte.
- Identificar las similitudes, diferencias y brechas en la organización de los servicios farmacéuticos, el acceso a la atención farmacéutica y las calificaciones del personal.
Principales métodos:
- Estudio comparativo de los marcos legislativos.
- Análisis de las estructuras organizativas, el acceso de la población y los requisitos de personal.
Principales resultados:
- Ambos países superan la proporción media europea de farmacias por población, con concentraciones en las zonas urbanas.
- Bulgaria se enfrenta a desafíos en el acceso farmacéutico rural, mientras que Macedonia del Norte demuestra una mejor provisión en estas áreas.
Conclusiones:
- Los entornos normativos para las farmacias comunitarias difieren entre Bulgaria y Macedonia del Norte, especialmente en lo que respecta al acceso rural.
- Los resultados son relevantes para las reformas de los sistemas de salud y los procesos de adhesión a la UE en contextos similares.
Palabras clave:
Países BajosLa Unión EuropeaMacedonia del NorteFarmacias comunitariaslegislación farmacéuticaLos farmacéuticosMás Videos Relacionados
Videos de Conceptos Relacionados
01:03Drug Control Governance: Regulatory Bodies and Their Impact
240
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
240
01:12Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
01:19Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
01:25Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
223
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
223